A Japan-based global pharmaceutical manufacturer focused on developing and commercializing therapies for oncology, rare diseases, gastroenterology, and plasma-derived treatments. The company operates a large international footprint following its acquisition of Shire, with significant revenue exposur...
7 members of Congress have disclosed 13 trades in Takeda Pharmaceutical Company Limited (TAK), a Healthcare company. The buy/sell breakdown shows 6 purchases versus 7 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-02-13 | Rohit Khanna | sell | $1K – $15K |
| 2024-12-13 | Rohit Khanna | sell | $1K – $15K |
| 2023-08-29 | Virginia Foxx | sell | $15K – $50K |
| 2023-07-10 | Daniel Goldman | sell | $15K – $50K |
| 2023-05-19 | Rohit Khanna | buy | $1K – $15K |
| 2023-02-27 | Daniel Goldman | buy | $1K – $15K |
| 2023-02-16 | Virginia Foxx | buy | $1K – $15K |
| 2022-11-01 | Virginia Foxx | buy | $1K – $15K |
| 2019-09-11 | Greg Gianforte | sell | $1K – $15K |
| 2019-01-28 | CHARLES J. "CHUCK" FLEISCHMANN | sell | $1K – $15K |
| 2018-12-21 | Greg Gianforte | buy | $15K – $50K |
| 2015-04-01 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2014-04-03 | KENNY MARCHANT | buy | $1K – $15K |